Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with type I diabetes mellitus

Diabetic Medicine

Volumn 16, Issue 4, 1999, Pages 312-318

  Henriksen, Jan Erik ^a   Andersen, C Bruun ^a   Hother Nielsen, O ^a   Vaag, A ^a   Mortensen, S Aage ^b   Beck Nielsen, H ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Hypoglycaemia; Insulin treatment; Type 1 diabetes mellitus; Ubiquinone (coenzyme Q10)

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN; UBIDECARENONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; RANDOMIZED CONTROLLED TRIAL; WELLBEING;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; TREATMENT OUTCOME; UBIQUINONE;

EID: 0032757898     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00064.x     Document Type: Article

References (36)

1. 1 Beyer J, Nordenbrand K, Ernster L. The function of coenzyme Q in free radical production and as an antioxidant: a review, Chem Scripta 1987; 27: 145-153.
2. 10 content of the average Danish diet. Int J Vitam Nutr Res 1997; 67: 123-129.
3. 10 Molec Aspects Med 1994; 15 (Suppl.): s265-s272.
4. 10. Proc Natl Acad Sci USA 1985; 82: 901-904.
5. 10 therapy: a major advance in the management of resistant myocardial failure. Drugs Exp Clin Res 1985; 11:581-593.
6. 10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol 1985; 56: 247-251.
7. 10. Int J Tissue React 1990; 12: 169-171.
8. 10. Proc Natl Acad Sci USA 1985; 82: 4240-4244.
9. 10 in essential hypertension. Molec Aspects Med 1994; 15 (Suppl.): s257-s263.
10. 10 on essential arterial hypertension. Curr Therap Res 1990; 47: 841-845.
11. 10 on essential hypertension, a double blind controlled study. In: Folkers K, Yamamura Y, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier Science Publisher, 1986; 337-343.
12. 12 Shigeta Y, Izumi K, Abe H. Effect of Coenzyme Q7 treatment on blood sugar and ketone bodies of diabetecs. J Vitaminol 1966; 12: 293-298.
13. 13 Silvestre Aillaud P, BenDahan D, Paquis Fluckinger V, Pouget J, Pelissier JF, Desnuelle C et al. Could coenzyme Q and L-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA? [letter]. Diabetologia 1995; 38: 1485-1486.
14. 10, alpha-tocopherol, and free cholesterol levels in sera from diabetic patients. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier Science Publishers, 1991: 151-158.
15. 15 McDonnell MG, Archbold GP. Plasma ubiquinol/cholesterol ratios in patients with hyperlipidaemia, those with diabetes mellitus and in patients requiring dialysis. Clin Chim Acta 1996; 253: 117-126.
16. 16 Kishi T, Kishi H, Watanabe T, Folkers K. Bioenergetics in clinical medicine. XI. Studies on coenzyme Q and diabetes mellitus. J Med 1976; 7: 307-321.
17. 10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 1998; 41: 584-588.
18. 18 McCarry MF, Rubin EJ. Rationales for micronutrient supplementation in diabetes. Med Hypotheses 1984; 13: 139-151.
19. 19 BenDahan D, Desnuelle C, Vanuxem D, Confort Gouny S, Figarella Branger D, Pellissier JF et al. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 1992; 42: 1203-1208.
20. 20 Mokan M, Mitrakou A, Veneman T, Ryan C, Korytkowski M, Cryer P et al. Hypoglycemia unawareness in IDDM. Diabetes Care 1994; 17: 1397-1403.
21. 21 Beck Niclsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 94: 1714-1721.
22. 22 Hemmilä I, Dakubu S, Mukkala V, Siitari H, Lövgren T. Europium as a label in time-resolved immunofluorometric assays. Analytical Biochemistry 1984; 137: 335-343.
23. 10, alpha-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 1988; 425: 87-97.
24. 10 as an antioxidant in human plasma. Molec Aspects Med 1994; 15 (Suppl.): s97-s102.
25. 10, formulations in healthy volunteers. Molec Aspects Med 1994:15 (Suppl.):s273-s280.
26. 26 Paolisso G, D'Amore A, Volpe C, Balhi V, Saccomanno F, Galzerano D et al. Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients, Metabolism 1994; 43: 1426-1429.
27. 27 Paolisso G, D'Amore A, Balhi V, Volpe C, Galzerano D, Giugliano D et al. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol 1994; 266:E261-E268.
28. 28 Paolisso G, Di Maro G, Galzerano D, Cacciapuoti F, Varricchio G, Varrichio M et al. Pharmacological doses of vitamin E and insulin action in elderly subjects. AmJ Clin Nutr 1994; 59: 1291-1296.
29. 29 Paolisso G, D'Amore A, Galzerano D, Balbi V, Giugliano D, Varricchio M et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993; 11: 1433-1437.
30. 30 MacDonald MJ. Stimulation of insulin release from pancreatic islets by quinones. Biosci Rep 1991; 11: 165-170.
31. 10 and insulin secretion in vitro [letter]. Diabetes Res Clin Pract 1996; 33: 135-136.
32. 32 Asayama K, Uchida N, Nakane T, Hayashibe H, Dobashi K, Amemiya S et al. Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radic Biol Med 1993; 15: 597-602.
33. 33 Hunt JV, Wolff SP. Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radic Res Commun 1991; 12-13 Part 1: 115-123.
34. 34 Giugliano D, Acampora R, D'Onofrio F. Medical hypothesis: cardiovascular complications of diabetes mellitus-from glucose to insulin and back. Diabete Metab 1994; 20; 445-453.
35. 35 Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 1995; 44: 363-368.
36. 36 Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449.